Louis Denis

Louis Denis

Company: Verastem. inc

Job title: Chief Medical Officer


Clinical Development of RAF/MEK clamp VS-6766; Breakthrough Designation & Beyond 5:00 pm

RAF/MEK clamp VS-6766 and FAK inhibitor defactinib are in clinical development in RAS/MAPK driven cancers Clinical experience and progress in recurrent low-grade serous ovarian cancer (LGSOC) and KRAS mutant NSCLC will be presented Future directions will be discussed – including clinical trials in new indications and combination treatment approachesRead more

day: Day One Track I

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.